Global Nuclear Medicine Radioisotopes Market Research Report 2024(Status and Outlook)
![](/report_cover/11711/global-nuclear-medicine-radioisotopes-market-research-report-2022status-n-outlook_en.gif)
Report Overview:
Nuclear medicine has a huge potential in treating cancer and cardiac diseases. Growth of medical imaging is an opportunity for the growth of the global nuclear medicine radioisotope market, as both markets are correlated. Radiopharmaceuticals are approved by the Food and Drug Administration (FDA) as either drugs or biologics.
The Global Nuclear Medicine Radioisotopes Market Size was estimated at USD 3699.80 million in 2023 and is projected to reach USD 4495.52 million by 2029, exhibiting a CAGR of 3.30% during the forecast period.
This report provides a deep insight into the global Nuclear Medicine Radioisotopes market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Nuclear Medicine Radioisotopes Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Nuclear Medicine Radioisotopes market in any manner.
Global Nuclear Medicine Radioisotopes Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Agfa-Gevaert Group
Braco
Cardiarc
Cardinal Health
CMR Naviscan (Gamma Medica Inc.)
Curium
Digirad
GE Healthcare
Nordion (Canada)
NTP Radioisotopes SOC
Positron
Segami
Siemens Healthcare
Market Segmentation (by Type)
Thallium-201 (Tl-201)
Iodine (I-123)
Fluorine-18
Rubidium-82 (Rb-82)
Other
Market Segmentation (by Application)
Tumor
Heart Disease
Lymphoma
Thyroid Gland
Other
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Nuclear Medicine Radioisotopes Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
Nuclear medicine has a huge potential in treating cancer and cardiac diseases. Growth of medical imaging is an opportunity for the growth of the global nuclear medicine radioisotope market, as both markets are correlated. Radiopharmaceuticals are approved by the Food and Drug Administration (FDA) as either drugs or biologics.
The Global Nuclear Medicine Radioisotopes Market Size was estimated at USD 3699.80 million in 2023 and is projected to reach USD 4495.52 million by 2029, exhibiting a CAGR of 3.30% during the forecast period.
This report provides a deep insight into the global Nuclear Medicine Radioisotopes market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Nuclear Medicine Radioisotopes Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Nuclear Medicine Radioisotopes market in any manner.
Global Nuclear Medicine Radioisotopes Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Agfa-Gevaert Group
Braco
Cardiarc
Cardinal Health
CMR Naviscan (Gamma Medica Inc.)
Curium
Digirad
GE Healthcare
Nordion (Canada)
NTP Radioisotopes SOC
Positron
Segami
Siemens Healthcare
Market Segmentation (by Type)
Thallium-201 (Tl-201)
Iodine (I-123)
Fluorine-18
Rubidium-82 (Rb-82)
Other
Market Segmentation (by Application)
Tumor
Heart Disease
Lymphoma
Thyroid Gland
Other
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Nuclear Medicine Radioisotopes Market
- Overview of the regional outlook of the Nuclear Medicine Radioisotopes Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Nuclear Medicine Radioisotopes Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Nuclear Medicine Radioisotopes
1.2 Key Market Segments
1.2.1 Nuclear Medicine Radioisotopes Segment by Type
1.2.2 Nuclear Medicine Radioisotopes Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 NUCLEAR MEDICINE RADIOISOTOPES MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Nuclear Medicine Radioisotopes Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Nuclear Medicine Radioisotopes Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 NUCLEAR MEDICINE RADIOISOTOPES MARKET COMPETITIVE LANDSCAPE
3.1 Global Nuclear Medicine Radioisotopes Sales by Manufacturers (2019-2024)
3.2 Global Nuclear Medicine Radioisotopes Revenue Market Share by Manufacturers (2019-2024)
3.3 Nuclear Medicine Radioisotopes Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Nuclear Medicine Radioisotopes Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Nuclear Medicine Radioisotopes Sales Sites, Area Served, Product Type
3.6 Nuclear Medicine Radioisotopes Market Competitive Situation and Trends
3.6.1 Nuclear Medicine Radioisotopes Market Concentration Rate
3.6.2 Global 5 and 10 Largest Nuclear Medicine Radioisotopes Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 NUCLEAR MEDICINE RADIOISOTOPES INDUSTRY CHAIN ANALYSIS
4.1 Nuclear Medicine Radioisotopes Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF NUCLEAR MEDICINE RADIOISOTOPES MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 NUCLEAR MEDICINE RADIOISOTOPES MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Nuclear Medicine Radioisotopes Sales Market Share by Type (2019-2024)
6.3 Global Nuclear Medicine Radioisotopes Market Size Market Share by Type (2019-2024)
6.4 Global Nuclear Medicine Radioisotopes Price by Type (2019-2024)
7 NUCLEAR MEDICINE RADIOISOTOPES MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Nuclear Medicine Radioisotopes Market Sales by Application (2019-2024)
7.3 Global Nuclear Medicine Radioisotopes Market Size (M USD) by Application (2019-2024)
7.4 Global Nuclear Medicine Radioisotopes Sales Growth Rate by Application (2019-2024)
8 NUCLEAR MEDICINE RADIOISOTOPES MARKET SEGMENTATION BY REGION
8.1 Global Nuclear Medicine Radioisotopes Sales by Region
8.1.1 Global Nuclear Medicine Radioisotopes Sales by Region
8.1.2 Global Nuclear Medicine Radioisotopes Sales Market Share by Region
8.2 North America
8.2.1 North America Nuclear Medicine Radioisotopes Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Nuclear Medicine Radioisotopes Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Nuclear Medicine Radioisotopes Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Nuclear Medicine Radioisotopes Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Nuclear Medicine Radioisotopes Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Agfa-Gevaert Group
9.1.1 Agfa-Gevaert Group Nuclear Medicine Radioisotopes Basic Information
9.1.2 Agfa-Gevaert Group Nuclear Medicine Radioisotopes Product Overview
9.1.3 Agfa-Gevaert Group Nuclear Medicine Radioisotopes Product Market Performance
9.1.4 Agfa-Gevaert Group Business Overview
9.1.5 Agfa-Gevaert Group Nuclear Medicine Radioisotopes SWOT Analysis
9.1.6 Agfa-Gevaert Group Recent Developments
9.2 Braco
9.2.1 Braco Nuclear Medicine Radioisotopes Basic Information
9.2.2 Braco Nuclear Medicine Radioisotopes Product Overview
9.2.3 Braco Nuclear Medicine Radioisotopes Product Market Performance
9.2.4 Braco Business Overview
9.2.5 Braco Nuclear Medicine Radioisotopes SWOT Analysis
9.2.6 Braco Recent Developments
9.3 Cardiarc
9.3.1 Cardiarc Nuclear Medicine Radioisotopes Basic Information
9.3.2 Cardiarc Nuclear Medicine Radioisotopes Product Overview
9.3.3 Cardiarc Nuclear Medicine Radioisotopes Product Market Performance
9.3.4 Cardiarc Nuclear Medicine Radioisotopes SWOT Analysis
9.3.5 Cardiarc Business Overview
9.3.6 Cardiarc Recent Developments
9.4 Cardinal Health
9.4.1 Cardinal Health Nuclear Medicine Radioisotopes Basic Information
9.4.2 Cardinal Health Nuclear Medicine Radioisotopes Product Overview
9.4.3 Cardinal Health Nuclear Medicine Radioisotopes Product Market Performance
9.4.4 Cardinal Health Business Overview
9.4.5 Cardinal Health Recent Developments
9.5 CMR Naviscan (Gamma Medica Inc.)
9.5.1 CMR Naviscan (Gamma Medica Inc.) Nuclear Medicine Radioisotopes Basic Information
9.5.2 CMR Naviscan (Gamma Medica Inc.) Nuclear Medicine Radioisotopes Product Overview
9.5.3 CMR Naviscan (Gamma Medica Inc.) Nuclear Medicine Radioisotopes Product Market Performance
9.5.4 CMR Naviscan (Gamma Medica Inc.) Business Overview
9.5.5 CMR Naviscan (Gamma Medica Inc.) Recent Developments
9.6 Curium
9.6.1 Curium Nuclear Medicine Radioisotopes Basic Information
9.6.2 Curium Nuclear Medicine Radioisotopes Product Overview
9.6.3 Curium Nuclear Medicine Radioisotopes Product Market Performance
9.6.4 Curium Business Overview
9.6.5 Curium Recent Developments
9.7 Digirad
9.7.1 Digirad Nuclear Medicine Radioisotopes Basic Information
9.7.2 Digirad Nuclear Medicine Radioisotopes Product Overview
9.7.3 Digirad Nuclear Medicine Radioisotopes Product Market Performance
9.7.4 Digirad Business Overview
9.7.5 Digirad Recent Developments
9.8 GE Healthcare
9.8.1 GE Healthcare Nuclear Medicine Radioisotopes Basic Information
9.8.2 GE Healthcare Nuclear Medicine Radioisotopes Product Overview
9.8.3 GE Healthcare Nuclear Medicine Radioisotopes Product Market Performance
9.8.4 GE Healthcare Business Overview
9.8.5 GE Healthcare Recent Developments
9.9 Nordion (Canada)
9.9.1 Nordion (Canada) Nuclear Medicine Radioisotopes Basic Information
9.9.2 Nordion (Canada) Nuclear Medicine Radioisotopes Product Overview
9.9.3 Nordion (Canada) Nuclear Medicine Radioisotopes Product Market Performance
9.9.4 Nordion (Canada) Business Overview
9.9.5 Nordion (Canada) Recent Developments
9.10 NTP Radioisotopes SOC
9.10.1 NTP Radioisotopes SOC Nuclear Medicine Radioisotopes Basic Information
9.10.2 NTP Radioisotopes SOC Nuclear Medicine Radioisotopes Product Overview
9.10.3 NTP Radioisotopes SOC Nuclear Medicine Radioisotopes Product Market Performance
9.10.4 NTP Radioisotopes SOC Business Overview
9.10.5 NTP Radioisotopes SOC Recent Developments
9.11 Positron
9.11.1 Positron Nuclear Medicine Radioisotopes Basic Information
9.11.2 Positron Nuclear Medicine Radioisotopes Product Overview
9.11.3 Positron Nuclear Medicine Radioisotopes Product Market Performance
9.11.4 Positron Business Overview
9.11.5 Positron Recent Developments
9.12 Segami
9.12.1 Segami Nuclear Medicine Radioisotopes Basic Information
9.12.2 Segami Nuclear Medicine Radioisotopes Product Overview
9.12.3 Segami Nuclear Medicine Radioisotopes Product Market Performance
9.12.4 Segami Business Overview
9.12.5 Segami Recent Developments
9.13 Siemens Healthcare
9.13.1 Siemens Healthcare Nuclear Medicine Radioisotopes Basic Information
9.13.2 Siemens Healthcare Nuclear Medicine Radioisotopes Product Overview
9.13.3 Siemens Healthcare Nuclear Medicine Radioisotopes Product Market Performance
9.13.4 Siemens Healthcare Business Overview
9.13.5 Siemens Healthcare Recent Developments
10 NUCLEAR MEDICINE RADIOISOTOPES MARKET FORECAST BY REGION
10.1 Global Nuclear Medicine Radioisotopes Market Size Forecast
10.2 Global Nuclear Medicine Radioisotopes Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Nuclear Medicine Radioisotopes Market Size Forecast by Country
10.2.3 Asia Pacific Nuclear Medicine Radioisotopes Market Size Forecast by Region
10.2.4 South America Nuclear Medicine Radioisotopes Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Nuclear Medicine Radioisotopes by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Nuclear Medicine Radioisotopes Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Nuclear Medicine Radioisotopes by Type (2025-2030)
11.1.2 Global Nuclear Medicine Radioisotopes Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Nuclear Medicine Radioisotopes by Type (2025-2030)
11.2 Global Nuclear Medicine Radioisotopes Market Forecast by Application (2025-2030)
11.2.1 Global Nuclear Medicine Radioisotopes Sales (K Units) Forecast by Application
11.2.2 Global Nuclear Medicine Radioisotopes Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Nuclear Medicine Radioisotopes
1.2 Key Market Segments
1.2.1 Nuclear Medicine Radioisotopes Segment by Type
1.2.2 Nuclear Medicine Radioisotopes Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 NUCLEAR MEDICINE RADIOISOTOPES MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Nuclear Medicine Radioisotopes Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Nuclear Medicine Radioisotopes Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 NUCLEAR MEDICINE RADIOISOTOPES MARKET COMPETITIVE LANDSCAPE
3.1 Global Nuclear Medicine Radioisotopes Sales by Manufacturers (2019-2024)
3.2 Global Nuclear Medicine Radioisotopes Revenue Market Share by Manufacturers (2019-2024)
3.3 Nuclear Medicine Radioisotopes Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Nuclear Medicine Radioisotopes Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Nuclear Medicine Radioisotopes Sales Sites, Area Served, Product Type
3.6 Nuclear Medicine Radioisotopes Market Competitive Situation and Trends
3.6.1 Nuclear Medicine Radioisotopes Market Concentration Rate
3.6.2 Global 5 and 10 Largest Nuclear Medicine Radioisotopes Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 NUCLEAR MEDICINE RADIOISOTOPES INDUSTRY CHAIN ANALYSIS
4.1 Nuclear Medicine Radioisotopes Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF NUCLEAR MEDICINE RADIOISOTOPES MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 NUCLEAR MEDICINE RADIOISOTOPES MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Nuclear Medicine Radioisotopes Sales Market Share by Type (2019-2024)
6.3 Global Nuclear Medicine Radioisotopes Market Size Market Share by Type (2019-2024)
6.4 Global Nuclear Medicine Radioisotopes Price by Type (2019-2024)
7 NUCLEAR MEDICINE RADIOISOTOPES MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Nuclear Medicine Radioisotopes Market Sales by Application (2019-2024)
7.3 Global Nuclear Medicine Radioisotopes Market Size (M USD) by Application (2019-2024)
7.4 Global Nuclear Medicine Radioisotopes Sales Growth Rate by Application (2019-2024)
8 NUCLEAR MEDICINE RADIOISOTOPES MARKET SEGMENTATION BY REGION
8.1 Global Nuclear Medicine Radioisotopes Sales by Region
8.1.1 Global Nuclear Medicine Radioisotopes Sales by Region
8.1.2 Global Nuclear Medicine Radioisotopes Sales Market Share by Region
8.2 North America
8.2.1 North America Nuclear Medicine Radioisotopes Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Nuclear Medicine Radioisotopes Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Nuclear Medicine Radioisotopes Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Nuclear Medicine Radioisotopes Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Nuclear Medicine Radioisotopes Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Agfa-Gevaert Group
9.1.1 Agfa-Gevaert Group Nuclear Medicine Radioisotopes Basic Information
9.1.2 Agfa-Gevaert Group Nuclear Medicine Radioisotopes Product Overview
9.1.3 Agfa-Gevaert Group Nuclear Medicine Radioisotopes Product Market Performance
9.1.4 Agfa-Gevaert Group Business Overview
9.1.5 Agfa-Gevaert Group Nuclear Medicine Radioisotopes SWOT Analysis
9.1.6 Agfa-Gevaert Group Recent Developments
9.2 Braco
9.2.1 Braco Nuclear Medicine Radioisotopes Basic Information
9.2.2 Braco Nuclear Medicine Radioisotopes Product Overview
9.2.3 Braco Nuclear Medicine Radioisotopes Product Market Performance
9.2.4 Braco Business Overview
9.2.5 Braco Nuclear Medicine Radioisotopes SWOT Analysis
9.2.6 Braco Recent Developments
9.3 Cardiarc
9.3.1 Cardiarc Nuclear Medicine Radioisotopes Basic Information
9.3.2 Cardiarc Nuclear Medicine Radioisotopes Product Overview
9.3.3 Cardiarc Nuclear Medicine Radioisotopes Product Market Performance
9.3.4 Cardiarc Nuclear Medicine Radioisotopes SWOT Analysis
9.3.5 Cardiarc Business Overview
9.3.6 Cardiarc Recent Developments
9.4 Cardinal Health
9.4.1 Cardinal Health Nuclear Medicine Radioisotopes Basic Information
9.4.2 Cardinal Health Nuclear Medicine Radioisotopes Product Overview
9.4.3 Cardinal Health Nuclear Medicine Radioisotopes Product Market Performance
9.4.4 Cardinal Health Business Overview
9.4.5 Cardinal Health Recent Developments
9.5 CMR Naviscan (Gamma Medica Inc.)
9.5.1 CMR Naviscan (Gamma Medica Inc.) Nuclear Medicine Radioisotopes Basic Information
9.5.2 CMR Naviscan (Gamma Medica Inc.) Nuclear Medicine Radioisotopes Product Overview
9.5.3 CMR Naviscan (Gamma Medica Inc.) Nuclear Medicine Radioisotopes Product Market Performance
9.5.4 CMR Naviscan (Gamma Medica Inc.) Business Overview
9.5.5 CMR Naviscan (Gamma Medica Inc.) Recent Developments
9.6 Curium
9.6.1 Curium Nuclear Medicine Radioisotopes Basic Information
9.6.2 Curium Nuclear Medicine Radioisotopes Product Overview
9.6.3 Curium Nuclear Medicine Radioisotopes Product Market Performance
9.6.4 Curium Business Overview
9.6.5 Curium Recent Developments
9.7 Digirad
9.7.1 Digirad Nuclear Medicine Radioisotopes Basic Information
9.7.2 Digirad Nuclear Medicine Radioisotopes Product Overview
9.7.3 Digirad Nuclear Medicine Radioisotopes Product Market Performance
9.7.4 Digirad Business Overview
9.7.5 Digirad Recent Developments
9.8 GE Healthcare
9.8.1 GE Healthcare Nuclear Medicine Radioisotopes Basic Information
9.8.2 GE Healthcare Nuclear Medicine Radioisotopes Product Overview
9.8.3 GE Healthcare Nuclear Medicine Radioisotopes Product Market Performance
9.8.4 GE Healthcare Business Overview
9.8.5 GE Healthcare Recent Developments
9.9 Nordion (Canada)
9.9.1 Nordion (Canada) Nuclear Medicine Radioisotopes Basic Information
9.9.2 Nordion (Canada) Nuclear Medicine Radioisotopes Product Overview
9.9.3 Nordion (Canada) Nuclear Medicine Radioisotopes Product Market Performance
9.9.4 Nordion (Canada) Business Overview
9.9.5 Nordion (Canada) Recent Developments
9.10 NTP Radioisotopes SOC
9.10.1 NTP Radioisotopes SOC Nuclear Medicine Radioisotopes Basic Information
9.10.2 NTP Radioisotopes SOC Nuclear Medicine Radioisotopes Product Overview
9.10.3 NTP Radioisotopes SOC Nuclear Medicine Radioisotopes Product Market Performance
9.10.4 NTP Radioisotopes SOC Business Overview
9.10.5 NTP Radioisotopes SOC Recent Developments
9.11 Positron
9.11.1 Positron Nuclear Medicine Radioisotopes Basic Information
9.11.2 Positron Nuclear Medicine Radioisotopes Product Overview
9.11.3 Positron Nuclear Medicine Radioisotopes Product Market Performance
9.11.4 Positron Business Overview
9.11.5 Positron Recent Developments
9.12 Segami
9.12.1 Segami Nuclear Medicine Radioisotopes Basic Information
9.12.2 Segami Nuclear Medicine Radioisotopes Product Overview
9.12.3 Segami Nuclear Medicine Radioisotopes Product Market Performance
9.12.4 Segami Business Overview
9.12.5 Segami Recent Developments
9.13 Siemens Healthcare
9.13.1 Siemens Healthcare Nuclear Medicine Radioisotopes Basic Information
9.13.2 Siemens Healthcare Nuclear Medicine Radioisotopes Product Overview
9.13.3 Siemens Healthcare Nuclear Medicine Radioisotopes Product Market Performance
9.13.4 Siemens Healthcare Business Overview
9.13.5 Siemens Healthcare Recent Developments
10 NUCLEAR MEDICINE RADIOISOTOPES MARKET FORECAST BY REGION
10.1 Global Nuclear Medicine Radioisotopes Market Size Forecast
10.2 Global Nuclear Medicine Radioisotopes Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Nuclear Medicine Radioisotopes Market Size Forecast by Country
10.2.3 Asia Pacific Nuclear Medicine Radioisotopes Market Size Forecast by Region
10.2.4 South America Nuclear Medicine Radioisotopes Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Nuclear Medicine Radioisotopes by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Nuclear Medicine Radioisotopes Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Nuclear Medicine Radioisotopes by Type (2025-2030)
11.1.2 Global Nuclear Medicine Radioisotopes Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Nuclear Medicine Radioisotopes by Type (2025-2030)
11.2 Global Nuclear Medicine Radioisotopes Market Forecast by Application (2025-2030)
11.2.1 Global Nuclear Medicine Radioisotopes Sales (K Units) Forecast by Application
11.2.2 Global Nuclear Medicine Radioisotopes Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Nuclear Medicine Radioisotopes Market Size Comparison by Region (M USD)
Table 5. Global Nuclear Medicine Radioisotopes Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Nuclear Medicine Radioisotopes Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Nuclear Medicine Radioisotopes Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Nuclear Medicine Radioisotopes Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nuclear Medicine Radioisotopes as of 2022)
Table 10. Global Market Nuclear Medicine Radioisotopes Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Nuclear Medicine Radioisotopes Sales Sites and Area Served
Table 12. Manufacturers Nuclear Medicine Radioisotopes Product Type
Table 13. Global Nuclear Medicine Radioisotopes Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Nuclear Medicine Radioisotopes
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Nuclear Medicine Radioisotopes Market Challenges
Table 22. Global Nuclear Medicine Radioisotopes Sales by Type (K Units)
Table 23. Global Nuclear Medicine Radioisotopes Market Size by Type (M USD)
Table 24. Global Nuclear Medicine Radioisotopes Sales (K Units) by Type (2019-2024)
Table 25. Global Nuclear Medicine Radioisotopes Sales Market Share by Type (2019-2024)
Table 26. Global Nuclear Medicine Radioisotopes Market Size (M USD) by Type (2019-2024)
Table 27. Global Nuclear Medicine Radioisotopes Market Size Share by Type (2019-2024)
Table 28. Global Nuclear Medicine Radioisotopes Price (USD/Unit) by Type (2019-2024)
Table 29. Global Nuclear Medicine Radioisotopes Sales (K Units) by Application
Table 30. Global Nuclear Medicine Radioisotopes Market Size by Application
Table 31. Global Nuclear Medicine Radioisotopes Sales by Application (2019-2024) & (K Units)
Table 32. Global Nuclear Medicine Radioisotopes Sales Market Share by Application (2019-2024)
Table 33. Global Nuclear Medicine Radioisotopes Sales by Application (2019-2024) & (M USD)
Table 34. Global Nuclear Medicine Radioisotopes Market Share by Application (2019-2024)
Table 35. Global Nuclear Medicine Radioisotopes Sales Growth Rate by Application (2019-2024)
Table 36. Global Nuclear Medicine Radioisotopes Sales by Region (2019-2024) & (K Units)
Table 37. Global Nuclear Medicine Radioisotopes Sales Market Share by Region (2019-2024)
Table 38. North America Nuclear Medicine Radioisotopes Sales by Country (2019-2024) & (K Units)
Table 39. Europe Nuclear Medicine Radioisotopes Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Nuclear Medicine Radioisotopes Sales by Region (2019-2024) & (K Units)
Table 41. South America Nuclear Medicine Radioisotopes Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Nuclear Medicine Radioisotopes Sales by Region (2019-2024) & (K Units)
Table 43. Agfa-Gevaert Group Nuclear Medicine Radioisotopes Basic Information
Table 44. Agfa-Gevaert Group Nuclear Medicine Radioisotopes Product Overview
Table 45. Agfa-Gevaert Group Nuclear Medicine Radioisotopes Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Agfa-Gevaert Group Business Overview
Table 47. Agfa-Gevaert Group Nuclear Medicine Radioisotopes SWOT Analysis
Table 48. Agfa-Gevaert Group Recent Developments
Table 49. Braco Nuclear Medicine Radioisotopes Basic Information
Table 50. Braco Nuclear Medicine Radioisotopes Product Overview
Table 51. Braco Nuclear Medicine Radioisotopes Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Braco Business Overview
Table 53. Braco Nuclear Medicine Radioisotopes SWOT Analysis
Table 54. Braco Recent Developments
Table 55. Cardiarc Nuclear Medicine Radioisotopes Basic Information
Table 56. Cardiarc Nuclear Medicine Radioisotopes Product Overview
Table 57. Cardiarc Nuclear Medicine Radioisotopes Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Cardiarc Nuclear Medicine Radioisotopes SWOT Analysis
Table 59. Cardiarc Business Overview
Table 60. Cardiarc Recent Developments
Table 61. Cardinal Health Nuclear Medicine Radioisotopes Basic Information
Table 62. Cardinal Health Nuclear Medicine Radioisotopes Product Overview
Table 63. Cardinal Health Nuclear Medicine Radioisotopes Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Cardinal Health Business Overview
Table 65. Cardinal Health Recent Developments
Table 66. CMR Naviscan (Gamma Medica Inc.) Nuclear Medicine Radioisotopes Basic Information
Table 67. CMR Naviscan (Gamma Medica Inc.) Nuclear Medicine Radioisotopes Product Overview
Table 68. CMR Naviscan (Gamma Medica Inc.) Nuclear Medicine Radioisotopes Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. CMR Naviscan (Gamma Medica Inc.) Business Overview
Table 70. CMR Naviscan (Gamma Medica Inc.) Recent Developments
Table 71. Curium Nuclear Medicine Radioisotopes Basic Information
Table 72. Curium Nuclear Medicine Radioisotopes Product Overview
Table 73. Curium Nuclear Medicine Radioisotopes Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Curium Business Overview
Table 75. Curium Recent Developments
Table 76. Digirad Nuclear Medicine Radioisotopes Basic Information
Table 77. Digirad Nuclear Medicine Radioisotopes Product Overview
Table 78. Digirad Nuclear Medicine Radioisotopes Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Digirad Business Overview
Table 80. Digirad Recent Developments
Table 81. GE Healthcare Nuclear Medicine Radioisotopes Basic Information
Table 82. GE Healthcare Nuclear Medicine Radioisotopes Product Overview
Table 83. GE Healthcare Nuclear Medicine Radioisotopes Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. GE Healthcare Business Overview
Table 85. GE Healthcare Recent Developments
Table 86. Nordion (Canada) Nuclear Medicine Radioisotopes Basic Information
Table 87. Nordion (Canada) Nuclear Medicine Radioisotopes Product Overview
Table 88. Nordion (Canada) Nuclear Medicine Radioisotopes Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Nordion (Canada) Business Overview
Table 90. Nordion (Canada) Recent Developments
Table 91. NTP Radioisotopes SOC Nuclear Medicine Radioisotopes Basic Information
Table 92. NTP Radioisotopes SOC Nuclear Medicine Radioisotopes Product Overview
Table 93. NTP Radioisotopes SOC Nuclear Medicine Radioisotopes Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. NTP Radioisotopes SOC Business Overview
Table 95. NTP Radioisotopes SOC Recent Developments
Table 96. Positron Nuclear Medicine Radioisotopes Basic Information
Table 97. Positron Nuclear Medicine Radioisotopes Product Overview
Table 98. Positron Nuclear Medicine Radioisotopes Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Positron Business Overview
Table 100. Positron Recent Developments
Table 101. Segami Nuclear Medicine Radioisotopes Basic Information
Table 102. Segami Nuclear Medicine Radioisotopes Product Overview
Table 103. Segami Nuclear Medicine Radioisotopes Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. Segami Business Overview
Table 105. Segami Recent Developments
Table 106. Siemens Healthcare Nuclear Medicine Radioisotopes Basic Information
Table 107. Siemens Healthcare Nuclear Medicine Radioisotopes Product Overview
Table 108. Siemens Healthcare Nuclear Medicine Radioisotopes Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. Siemens Healthcare Business Overview
Table 110. Siemens Healthcare Recent Developments
Table 111. Global Nuclear Medicine Radioisotopes Sales Forecast by Region (2025-2030) & (K Units)
Table 112. Global Nuclear Medicine Radioisotopes Market Size Forecast by Region (2025-2030) & (M USD)
Table 113. North America Nuclear Medicine Radioisotopes Sales Forecast by Country (2025-2030) & (K Units)
Table 114. North America Nuclear Medicine Radioisotopes Market Size Forecast by Country (2025-2030) & (M USD)
Table 115. Europe Nuclear Medicine Radioisotopes Sales Forecast by Country (2025-2030) & (K Units)
Table 116. Europe Nuclear Medicine Radioisotopes Market Size Forecast by Country (2025-2030) & (M USD)
Table 117. Asia Pacific Nuclear Medicine Radioisotopes Sales Forecast by Region (2025-2030) & (K Units)
Table 118. Asia Pacific Nuclear Medicine Radioisotopes Market Size Forecast by Region (2025-2030) & (M USD)
Table 119. South America Nuclear Medicine Radioisotopes Sales Forecast by Country (2025-2030) & (K Units)
Table 120. South America Nuclear Medicine Radioisotopes Market Size Forecast by Country (2025-2030) & (M USD)
Table 121. Middle East and Africa Nuclear Medicine Radioisotopes Consumption Forecast by Country (2025-2030) & (Units)
Table 122. Middle East and Africa Nuclear Medicine Radioisotopes Market Size Forecast by Country (2025-2030) & (M USD)
Table 123. Global Nuclear Medicine Radioisotopes Sales Forecast by Type (2025-2030) & (K Units)
Table 124. Global Nuclear Medicine Radioisotopes Market Size Forecast by Type (2025-2030) & (M USD)
Table 125. Global Nuclear Medicine Radioisotopes Price Forecast by Type (2025-2030) & (USD/Unit)
Table 126. Global Nuclear Medicine Radioisotopes Sales (K Units) Forecast by Application (2025-2030)
Table 127. Global Nuclear Medicine Radioisotopes Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Nuclear Medicine Radioisotopes Market Size Comparison by Region (M USD)
Table 5. Global Nuclear Medicine Radioisotopes Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Nuclear Medicine Radioisotopes Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Nuclear Medicine Radioisotopes Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Nuclear Medicine Radioisotopes Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nuclear Medicine Radioisotopes as of 2022)
Table 10. Global Market Nuclear Medicine Radioisotopes Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Nuclear Medicine Radioisotopes Sales Sites and Area Served
Table 12. Manufacturers Nuclear Medicine Radioisotopes Product Type
Table 13. Global Nuclear Medicine Radioisotopes Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Nuclear Medicine Radioisotopes
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Nuclear Medicine Radioisotopes Market Challenges
Table 22. Global Nuclear Medicine Radioisotopes Sales by Type (K Units)
Table 23. Global Nuclear Medicine Radioisotopes Market Size by Type (M USD)
Table 24. Global Nuclear Medicine Radioisotopes Sales (K Units) by Type (2019-2024)
Table 25. Global Nuclear Medicine Radioisotopes Sales Market Share by Type (2019-2024)
Table 26. Global Nuclear Medicine Radioisotopes Market Size (M USD) by Type (2019-2024)
Table 27. Global Nuclear Medicine Radioisotopes Market Size Share by Type (2019-2024)
Table 28. Global Nuclear Medicine Radioisotopes Price (USD/Unit) by Type (2019-2024)
Table 29. Global Nuclear Medicine Radioisotopes Sales (K Units) by Application
Table 30. Global Nuclear Medicine Radioisotopes Market Size by Application
Table 31. Global Nuclear Medicine Radioisotopes Sales by Application (2019-2024) & (K Units)
Table 32. Global Nuclear Medicine Radioisotopes Sales Market Share by Application (2019-2024)
Table 33. Global Nuclear Medicine Radioisotopes Sales by Application (2019-2024) & (M USD)
Table 34. Global Nuclear Medicine Radioisotopes Market Share by Application (2019-2024)
Table 35. Global Nuclear Medicine Radioisotopes Sales Growth Rate by Application (2019-2024)
Table 36. Global Nuclear Medicine Radioisotopes Sales by Region (2019-2024) & (K Units)
Table 37. Global Nuclear Medicine Radioisotopes Sales Market Share by Region (2019-2024)
Table 38. North America Nuclear Medicine Radioisotopes Sales by Country (2019-2024) & (K Units)
Table 39. Europe Nuclear Medicine Radioisotopes Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Nuclear Medicine Radioisotopes Sales by Region (2019-2024) & (K Units)
Table 41. South America Nuclear Medicine Radioisotopes Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Nuclear Medicine Radioisotopes Sales by Region (2019-2024) & (K Units)
Table 43. Agfa-Gevaert Group Nuclear Medicine Radioisotopes Basic Information
Table 44. Agfa-Gevaert Group Nuclear Medicine Radioisotopes Product Overview
Table 45. Agfa-Gevaert Group Nuclear Medicine Radioisotopes Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Agfa-Gevaert Group Business Overview
Table 47. Agfa-Gevaert Group Nuclear Medicine Radioisotopes SWOT Analysis
Table 48. Agfa-Gevaert Group Recent Developments
Table 49. Braco Nuclear Medicine Radioisotopes Basic Information
Table 50. Braco Nuclear Medicine Radioisotopes Product Overview
Table 51. Braco Nuclear Medicine Radioisotopes Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Braco Business Overview
Table 53. Braco Nuclear Medicine Radioisotopes SWOT Analysis
Table 54. Braco Recent Developments
Table 55. Cardiarc Nuclear Medicine Radioisotopes Basic Information
Table 56. Cardiarc Nuclear Medicine Radioisotopes Product Overview
Table 57. Cardiarc Nuclear Medicine Radioisotopes Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Cardiarc Nuclear Medicine Radioisotopes SWOT Analysis
Table 59. Cardiarc Business Overview
Table 60. Cardiarc Recent Developments
Table 61. Cardinal Health Nuclear Medicine Radioisotopes Basic Information
Table 62. Cardinal Health Nuclear Medicine Radioisotopes Product Overview
Table 63. Cardinal Health Nuclear Medicine Radioisotopes Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Cardinal Health Business Overview
Table 65. Cardinal Health Recent Developments
Table 66. CMR Naviscan (Gamma Medica Inc.) Nuclear Medicine Radioisotopes Basic Information
Table 67. CMR Naviscan (Gamma Medica Inc.) Nuclear Medicine Radioisotopes Product Overview
Table 68. CMR Naviscan (Gamma Medica Inc.) Nuclear Medicine Radioisotopes Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. CMR Naviscan (Gamma Medica Inc.) Business Overview
Table 70. CMR Naviscan (Gamma Medica Inc.) Recent Developments
Table 71. Curium Nuclear Medicine Radioisotopes Basic Information
Table 72. Curium Nuclear Medicine Radioisotopes Product Overview
Table 73. Curium Nuclear Medicine Radioisotopes Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Curium Business Overview
Table 75. Curium Recent Developments
Table 76. Digirad Nuclear Medicine Radioisotopes Basic Information
Table 77. Digirad Nuclear Medicine Radioisotopes Product Overview
Table 78. Digirad Nuclear Medicine Radioisotopes Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Digirad Business Overview
Table 80. Digirad Recent Developments
Table 81. GE Healthcare Nuclear Medicine Radioisotopes Basic Information
Table 82. GE Healthcare Nuclear Medicine Radioisotopes Product Overview
Table 83. GE Healthcare Nuclear Medicine Radioisotopes Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. GE Healthcare Business Overview
Table 85. GE Healthcare Recent Developments
Table 86. Nordion (Canada) Nuclear Medicine Radioisotopes Basic Information
Table 87. Nordion (Canada) Nuclear Medicine Radioisotopes Product Overview
Table 88. Nordion (Canada) Nuclear Medicine Radioisotopes Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Nordion (Canada) Business Overview
Table 90. Nordion (Canada) Recent Developments
Table 91. NTP Radioisotopes SOC Nuclear Medicine Radioisotopes Basic Information
Table 92. NTP Radioisotopes SOC Nuclear Medicine Radioisotopes Product Overview
Table 93. NTP Radioisotopes SOC Nuclear Medicine Radioisotopes Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. NTP Radioisotopes SOC Business Overview
Table 95. NTP Radioisotopes SOC Recent Developments
Table 96. Positron Nuclear Medicine Radioisotopes Basic Information
Table 97. Positron Nuclear Medicine Radioisotopes Product Overview
Table 98. Positron Nuclear Medicine Radioisotopes Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Positron Business Overview
Table 100. Positron Recent Developments
Table 101. Segami Nuclear Medicine Radioisotopes Basic Information
Table 102. Segami Nuclear Medicine Radioisotopes Product Overview
Table 103. Segami Nuclear Medicine Radioisotopes Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. Segami Business Overview
Table 105. Segami Recent Developments
Table 106. Siemens Healthcare Nuclear Medicine Radioisotopes Basic Information
Table 107. Siemens Healthcare Nuclear Medicine Radioisotopes Product Overview
Table 108. Siemens Healthcare Nuclear Medicine Radioisotopes Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. Siemens Healthcare Business Overview
Table 110. Siemens Healthcare Recent Developments
Table 111. Global Nuclear Medicine Radioisotopes Sales Forecast by Region (2025-2030) & (K Units)
Table 112. Global Nuclear Medicine Radioisotopes Market Size Forecast by Region (2025-2030) & (M USD)
Table 113. North America Nuclear Medicine Radioisotopes Sales Forecast by Country (2025-2030) & (K Units)
Table 114. North America Nuclear Medicine Radioisotopes Market Size Forecast by Country (2025-2030) & (M USD)
Table 115. Europe Nuclear Medicine Radioisotopes Sales Forecast by Country (2025-2030) & (K Units)
Table 116. Europe Nuclear Medicine Radioisotopes Market Size Forecast by Country (2025-2030) & (M USD)
Table 117. Asia Pacific Nuclear Medicine Radioisotopes Sales Forecast by Region (2025-2030) & (K Units)
Table 118. Asia Pacific Nuclear Medicine Radioisotopes Market Size Forecast by Region (2025-2030) & (M USD)
Table 119. South America Nuclear Medicine Radioisotopes Sales Forecast by Country (2025-2030) & (K Units)
Table 120. South America Nuclear Medicine Radioisotopes Market Size Forecast by Country (2025-2030) & (M USD)
Table 121. Middle East and Africa Nuclear Medicine Radioisotopes Consumption Forecast by Country (2025-2030) & (Units)
Table 122. Middle East and Africa Nuclear Medicine Radioisotopes Market Size Forecast by Country (2025-2030) & (M USD)
Table 123. Global Nuclear Medicine Radioisotopes Sales Forecast by Type (2025-2030) & (K Units)
Table 124. Global Nuclear Medicine Radioisotopes Market Size Forecast by Type (2025-2030) & (M USD)
Table 125. Global Nuclear Medicine Radioisotopes Price Forecast by Type (2025-2030) & (USD/Unit)
Table 126. Global Nuclear Medicine Radioisotopes Sales (K Units) Forecast by Application (2025-2030)
Table 127. Global Nuclear Medicine Radioisotopes Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Nuclear Medicine Radioisotopes
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Nuclear Medicine Radioisotopes Market Size (M USD), 2019-2030
Figure 5. Global Nuclear Medicine Radioisotopes Market Size (M USD) (2019-2030)
Figure 6. Global Nuclear Medicine Radioisotopes Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Nuclear Medicine Radioisotopes Market Size by Country (M USD)
Figure 11. Nuclear Medicine Radioisotopes Sales Share by Manufacturers in 2023
Figure 12. Global Nuclear Medicine Radioisotopes Revenue Share by Manufacturers in 2023
Figure 13. Nuclear Medicine Radioisotopes Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Nuclear Medicine Radioisotopes Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Nuclear Medicine Radioisotopes Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Nuclear Medicine Radioisotopes Market Share by Type
Figure 18. Sales Market Share of Nuclear Medicine Radioisotopes by Type (2019-2024)
Figure 19. Sales Market Share of Nuclear Medicine Radioisotopes by Type in 2023
Figure 20. Market Size Share of Nuclear Medicine Radioisotopes by Type (2019-2024)
Figure 21. Market Size Market Share of Nuclear Medicine Radioisotopes by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Nuclear Medicine Radioisotopes Market Share by Application
Figure 24. Global Nuclear Medicine Radioisotopes Sales Market Share by Application (2019-2024)
Figure 25. Global Nuclear Medicine Radioisotopes Sales Market Share by Application in 2023
Figure 26. Global Nuclear Medicine Radioisotopes Market Share by Application (2019-2024)
Figure 27. Global Nuclear Medicine Radioisotopes Market Share by Application in 2023
Figure 28. Global Nuclear Medicine Radioisotopes Sales Growth Rate by Application (2019-2024)
Figure 29. Global Nuclear Medicine Radioisotopes Sales Market Share by Region (2019-2024)
Figure 30. North America Nuclear Medicine Radioisotopes Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Nuclear Medicine Radioisotopes Sales Market Share by Country in 2023
Figure 32. U.S. Nuclear Medicine Radioisotopes Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Nuclear Medicine Radioisotopes Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Nuclear Medicine Radioisotopes Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Nuclear Medicine Radioisotopes Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Nuclear Medicine Radioisotopes Sales Market Share by Country in 2023
Figure 37. Germany Nuclear Medicine Radioisotopes Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Nuclear Medicine Radioisotopes Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Nuclear Medicine Radioisotopes Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Nuclear Medicine Radioisotopes Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Nuclear Medicine Radioisotopes Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Nuclear Medicine Radioisotopes Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Nuclear Medicine Radioisotopes Sales Market Share by Region in 2023
Figure 44. China Nuclear Medicine Radioisotopes Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Nuclear Medicine Radioisotopes Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Nuclear Medicine Radioisotopes Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Nuclear Medicine Radioisotopes Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Nuclear Medicine Radioisotopes Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Nuclear Medicine Radioisotopes Sales and Growth Rate (K Units)
Figure 50. South America Nuclear Medicine Radioisotopes Sales Market Share by Country in 2023
Figure 51. Brazil Nuclear Medicine Radioisotopes Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Nuclear Medicine Radioisotopes Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Nuclear Medicine Radioisotopes Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Nuclear Medicine Radioisotopes Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Nuclear Medicine Radioisotopes Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Nuclear Medicine Radioisotopes Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Nuclear Medicine Radioisotopes Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Nuclear Medicine Radioisotopes Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Nuclear Medicine Radioisotopes Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Nuclear Medicine Radioisotopes Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Nuclear Medicine Radioisotopes Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Nuclear Medicine Radioisotopes Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Nuclear Medicine Radioisotopes Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Nuclear Medicine Radioisotopes Market Share Forecast by Type (2025-2030)
Figure 65. Global Nuclear Medicine Radioisotopes Sales Forecast by Application (2025-2030)
Figure 66. Global Nuclear Medicine Radioisotopes Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Nuclear Medicine Radioisotopes
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Nuclear Medicine Radioisotopes Market Size (M USD), 2019-2030
Figure 5. Global Nuclear Medicine Radioisotopes Market Size (M USD) (2019-2030)
Figure 6. Global Nuclear Medicine Radioisotopes Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Nuclear Medicine Radioisotopes Market Size by Country (M USD)
Figure 11. Nuclear Medicine Radioisotopes Sales Share by Manufacturers in 2023
Figure 12. Global Nuclear Medicine Radioisotopes Revenue Share by Manufacturers in 2023
Figure 13. Nuclear Medicine Radioisotopes Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Nuclear Medicine Radioisotopes Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Nuclear Medicine Radioisotopes Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Nuclear Medicine Radioisotopes Market Share by Type
Figure 18. Sales Market Share of Nuclear Medicine Radioisotopes by Type (2019-2024)
Figure 19. Sales Market Share of Nuclear Medicine Radioisotopes by Type in 2023
Figure 20. Market Size Share of Nuclear Medicine Radioisotopes by Type (2019-2024)
Figure 21. Market Size Market Share of Nuclear Medicine Radioisotopes by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Nuclear Medicine Radioisotopes Market Share by Application
Figure 24. Global Nuclear Medicine Radioisotopes Sales Market Share by Application (2019-2024)
Figure 25. Global Nuclear Medicine Radioisotopes Sales Market Share by Application in 2023
Figure 26. Global Nuclear Medicine Radioisotopes Market Share by Application (2019-2024)
Figure 27. Global Nuclear Medicine Radioisotopes Market Share by Application in 2023
Figure 28. Global Nuclear Medicine Radioisotopes Sales Growth Rate by Application (2019-2024)
Figure 29. Global Nuclear Medicine Radioisotopes Sales Market Share by Region (2019-2024)
Figure 30. North America Nuclear Medicine Radioisotopes Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Nuclear Medicine Radioisotopes Sales Market Share by Country in 2023
Figure 32. U.S. Nuclear Medicine Radioisotopes Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Nuclear Medicine Radioisotopes Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Nuclear Medicine Radioisotopes Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Nuclear Medicine Radioisotopes Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Nuclear Medicine Radioisotopes Sales Market Share by Country in 2023
Figure 37. Germany Nuclear Medicine Radioisotopes Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Nuclear Medicine Radioisotopes Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Nuclear Medicine Radioisotopes Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Nuclear Medicine Radioisotopes Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Nuclear Medicine Radioisotopes Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Nuclear Medicine Radioisotopes Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Nuclear Medicine Radioisotopes Sales Market Share by Region in 2023
Figure 44. China Nuclear Medicine Radioisotopes Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Nuclear Medicine Radioisotopes Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Nuclear Medicine Radioisotopes Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Nuclear Medicine Radioisotopes Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Nuclear Medicine Radioisotopes Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Nuclear Medicine Radioisotopes Sales and Growth Rate (K Units)
Figure 50. South America Nuclear Medicine Radioisotopes Sales Market Share by Country in 2023
Figure 51. Brazil Nuclear Medicine Radioisotopes Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Nuclear Medicine Radioisotopes Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Nuclear Medicine Radioisotopes Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Nuclear Medicine Radioisotopes Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Nuclear Medicine Radioisotopes Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Nuclear Medicine Radioisotopes Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Nuclear Medicine Radioisotopes Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Nuclear Medicine Radioisotopes Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Nuclear Medicine Radioisotopes Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Nuclear Medicine Radioisotopes Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Nuclear Medicine Radioisotopes Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Nuclear Medicine Radioisotopes Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Nuclear Medicine Radioisotopes Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Nuclear Medicine Radioisotopes Market Share Forecast by Type (2025-2030)
Figure 65. Global Nuclear Medicine Radioisotopes Sales Forecast by Application (2025-2030)
Figure 66. Global Nuclear Medicine Radioisotopes Market Share Forecast by Application (2025-2030)